Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Circulating Tumor Cells Market From 2025 To 2029?
There has been a rapid expansion in the size of the circulating tumor cells market in the past few years. The market, which was valued at $11.9 billion in 2024, is expected to rise to $13.27 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.5%. The growth seen in this historic period can be traced back to factors such as the rate of cancer occurrence, the role of clinical utility in cancer staging, the advent of liquid biopsy, the patient preference for minimally invasive tests, regulatory encouragement for liquid biopsies, and an emphasis on detecting cancer early.
Expectations are high for a swift expansion in the circulating tumor cells market in the coming years, with predictions placing it at $21.38 billion by 2029, reflecting a compound annual growth rate of 12.7%. Factors influencing this predicted increase during the projected term, included the utilization of point-of-care CTC tests, the uptake of microfluidics, efforts directed towards rare forms of cancer, standardizing of CTC assays, broadening the scope of CTC-dependent clinical trials, and the knock-on effects of economic and expanding market growth. Key trends in the anticipated period involve the evolution of CTC isolation techniques, heightened government funding for CTC related research, progress in CTC detection technology, the increased usage of liquid biopsies for tracking cancer, dovetailing with single-cell analysis and the incorporation of artificial intelligence technology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Circulating Tumor Cells Market?
The escalating rates of cancer are poised to fuel the growth of the circulating tumor cells market. Cancer is a condition characterized by the uncontrolled growth and spread of certain body cells. Circulating tumor cells play a crucial role in the early detection and diagnosis of this disease, thereby driving the market’s expansion. For example, the American Cancer Society Journals, a voluntary health body based in the U.S., anticipated in January 2023 that the country would experience 1,958,310 new cancer diagnoses and 609,820 cancer-related fatalities. Consequently, the increasing prevalence of cancer is a major driving force for the expansion of the circulating tumor cells market.
Which Key Market Segments Comprise the Circulating Tumor Cells Market and Drive Its Revenue Growth?
The circulating tumor cellsmarket covered in this report is segmented –
1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research
Subsegments:
1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes
3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp
Which Areas Are Leading Regions in the Circulating Tumor Cells Market Expansion Across the Globe?
North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Key Market Trends in theCirculating Tumor Cells Market Over the Coming Years?
Key advancements in product development are becoming a growing trend in the circulating tumor cells market. Major players in this sector are prioritizing the creation of pioneering products to cement their market presence. As an illustration, Bio-Rad Laboratories, Inc., a medical laboratory based in the US, introduced the Celselect Slides 2.0 in June 2024. This product is designed to elevate the capture of rare cells and circulating tumor cells (CTCs), thereby improving the precision and efficiency of cell analysis across clinical and research sectors.
View the full report here:
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report
How Is the Circulating Tumor Cells Market Conceptually Defined?
Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model